The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
You were right about the drop tricky, it really did dive down this time, sub $10 could be a good level for buying in.
The issue for me is that they keep missing parts of their guidance…..the share price reaction is almost like clockwork every single time. The Street clearly needs more convincing about their ability to hit all their guidance. Great product, but the competition is not going away either and take overs and mergers are starting to create some interesting dynamics.
I may well add /trade again as I usually do after the updates, but I am going to hold off for a little while this time as I am not sure the drop is done yet. All IMO. Hope everyone is ok.
"The last few weeks have been eventful as our management team debuted GAN Sports (our sports betting kiosk), our Super RGS platform and other new products at the Global Gaming Expo ("G2E") in Las Vegas. Our growing portfolio of products and content that roll up into our B2B product suite will further expand our position as a premier, holistic provider of technology solutions, popular games and original, exclusive content. We also provided a deep dive into our B2B and B2C strategies, the complexity and value of our technology, and showcased the depth and experience of our broader leadership team at our inaugural Investor Event in October. We believe these initiatives will ultimately yield over $500 million of revenue by 2026 and a long-term Adjusted EBITDA margin of 30-35% at scale. We continue to make exciting progress in each of our business segments and initiatives and are well-positioned going forward."
Price looks like it is starting to rise again, looks like positive news has landed now? GLA
Super quiet on this board nowadays. Took advantage of the usual trading update car crash to add at under 14 and sold at just under 18. Still leave my core holding but it got pretty predictable (well as predictable as these things ever get IMO), and it didn't disappoint.
Hope everyone is keeping well.....see you at the next update.
What will happen next, and how this might affect GAN.